Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1829

1.

Proteomics study of serum exosomes from papillary thyroid cancer patient.

Luo D, Zhan S, Xia W, Huang L, Ge W, Wang T.

Endocr Relat Cancer. 2018 Jun 12. pii: ERC-17-0547. doi: 10.1530/ERC-17-0547. [Epub ahead of print]

PMID:
29895528
2.

The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance.

Aristizabal Prada ET, Spoettl G, Maurer J, Lauseker M, Koziolek E, Schrader J, Grossman AB, Pacak K, Beuschlein F, Auernhammer CJ, Nölting S.

Endocr Relat Cancer. 2018 Jun 12. pii: ERC-18-0159. doi: 10.1530/ERC-18-0159. [Epub ahead of print]

PMID:
29895527
3.

Potent effects of roniciclib alone and with sorafenib against well-differentiated thyroid cancer.

Lin SF, Lin JD, Hsueh C, Chou TC, Wong RJ.

Endocr Relat Cancer. 2018 Jun 12. pii: ERC-18-0150. doi: 10.1530/ERC-18-0150. [Epub ahead of print]

PMID:
29895526
4.

The hypothalamic pituitary adrenal axis in childhood cancer survivors.

Wei C, Crowne E.

Endocr Relat Cancer. 2018 Jun 12. pii: ERC-18-0217. doi: 10.1530/ERC-18-0217. [Epub ahead of print]

PMID:
29895525
5.

Trastuzumab inhibits pituitary tumor growth modulating the TGFB/Smad2/3 pathway.

Petiti JP, Sosa LDV, Picech F, Moyano Crespo GD, Arevalo Rojas JZ, Pérez PA, Guido CB, Leimgruber C, Sabatino ME, García PE, Bengió V, Papalini FR, Estario P, Bernhardt MC, Villarreal M, Gutiérrez S, De Paul AL, Mukdsi JH, Torres AI.

Endocr Relat Cancer. 2018 Jun 6. pii: ERC-18-0067. doi: 10.1530/ERC-18-0067. [Epub ahead of print]

PMID:
29875136
6.

Simvastatin interferes with cancer 'stem-cell' plasticity reducing metastasis in ovarian cancer.

Kato S, Liberona MF, Cerda-Infante J, Sanchez M, Henriquez JF, Bizama C, Bravo ML, Gonzalez P, Gejman R, Branes J, García K, Ibañez C, Owen GI, Roa JC, Montecinos V, Cuello MA.

Endocr Relat Cancer. 2018 May 30. pii: ERC-18-0132. doi: 10.1530/ERC-18-0132. [Epub ahead of print]

PMID:
29848667
7.

Splicing dysregulation as a driver of breast cancer.

Read A, Natrajan R.

Endocr Relat Cancer. 2018 May 30. pii: ERC-18-0068. doi: 10.1530/ERC-18-0068. [Epub ahead of print]

PMID:
29848666
8.

Advances in adrenal tumors 2018.

Crona J, Beuschlein F, Pacak K, Skogseid B.

Endocr Relat Cancer. 2018 Jul;25(7):R405-R420. doi: 10.1530/ERC-18-0138. Review.

9.

Genetics Informs Precision Practice in the Diagnosis and Management of Pheochromocytoma.

Neumann HPH, Young W, Krauss T, Bayley JP, Schiavi F, Opocher G, Boedeker C, Tirosh A, Castinetti F, Ruf J, Beltsevich D, Walz MK, Groeben H, Von Dobschuetz E, Gimm O, Wohllk N, Pfeifer M, Lourenço DM, Peczkowska M, Patocs A, Ngeow J, Makay O, Shah N, Tischler AS, Leijon H, Pennelli G, Villar Gómez de Las Heras K, Links TP, Bausch B, Eng C.

Endocr Relat Cancer. 2018 May 24. pii: ERC-18-0085. doi: 10.1530/ERC-18-0085. [Epub ahead of print]

PMID:
29794110
10.

One gene - many endocrine and metabolic syndromes: PTEN-opathies and precision medicine.

Yehia L, Eng C.

Endocr Relat Cancer. 2018 May 23. pii: ERC-18-0162. doi: 10.1530/ERC-18-0162. [Epub ahead of print]

PMID:
29792313
11.

Intratumoral androgen levels are linked to TMPRSS2-ERG fusion in prostate cancer.

Knuuttila M, Mehmood A, Mäki-Jouppila J, Ryberg H, Taimen P, Knaapila J, Ettala O, Bostrom PJ, Ohlsson C, Venäläinen MS, Laiho A, Elo LL, Sipilä P, Makela S, Poutanen M.

Endocr Relat Cancer. 2018 May 17. pii: ERC-18-0148. doi: 10.1530/ERC-18-0148. [Epub ahead of print]

PMID:
29773553
12.

Emerging multitarget tyrosine kinase inhibitors in the treatment of neuroendocrine neoplasms.

Grillo F, Florio T, Ferraù F, Kara E, Fanciulli G, Faggiano A, Colao AAL.

Endocr Relat Cancer. 2018 May 16. pii: ERC-17-0531. doi: 10.1530/ERC-17-0531. [Epub ahead of print]

PMID:
29769293
13.

The role of IL-1B in breast cancer bone metastasis.

Tulotta C, Ottewell P.

Endocr Relat Cancer. 2018 Jul;25(7):R421-R434. doi: 10.1530/ERC-17-0309. Epub 2018 May 14. Review.

14.

The impact of transcription on metabolism in prostate and breast cancers.

Poulose N, Mills IG, Steele RE.

Endocr Relat Cancer. 2018 May 14. pii: ERC-18-0048. doi: 10.1530/ERC-18-0048. [Epub ahead of print]

PMID:
29760165
15.

Paediatric pancreatic neuroendocrine tumours in von Hippel-Lindau disease.

O'Toole SM, Sahdev A, Bhattacharya S, Feakins R, Gevers EF, Drake W.

Endocr Relat Cancer. 2018 May 11. pii: ERC-18-0123. doi: 10.1530/ERC-18-0123. [Epub ahead of print]

PMID:
29752349
16.

The endocrinology of male breast cancer.

Fentiman IS.

Endocr Relat Cancer. 2018 Jun;25(6):R365-R373. doi: 10.1530/ERC-18-0117. Review.

17.

Prolonged duration of response in lenvatinib responders with thyroid cancer.

Gianoukakis AG, Dutcus CE, Batty N, Guo M, Baig M.

Endocr Relat Cancer. 2018 Jun;25(6):699-704. doi: 10.1530/ERC-18-0049.

18.

Preventive medicine for von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.

Krauss T, Ferrara AM, Links TP, Wellner U, Bancos I, Kvachenyuk A, Villar Gómez de Las Heras K, Yukina M, Petrov R, Bullivant G, von Duecker L, Jadhav SS, Ploeckinger U, Welin S, Schalin-Jantti C, Gimm O, Pfeifer M, Ngeow J, Hasse-Lazar K, Sanso G, Qi XP, Ugurlu U, Diaz RE, Wohllk N, Peczkowska M, Aberle J, Lourenço DM Jr, Pereira MA, Fragoso MCBV, Hoff AO, Almeida MQ, Violante AHD, Quidute ARP, Zhang Z, Recasens M, Robles Diaz L, Kunavisarut T, Wannachalee T, Sirinvaravong S, Jonasch E, Grozinsky-Glasberg S, Fraenkel M, Beltsevich D, Egorov VI, Bausch D, Schott M, Tiling N, Pennelli G, Zschiedrich S, Därr R, Ruf J, Denecke T, Link KH, Zovato S, von Dobschuetz E, Yaremchuk S, Amthauer H, Makay O, Patocs A, Walz MK, Huber TB, Seufert J, Hellman P, Kim RH, Kuchinskaya E, Schiavi F, Malinoc A, Reisch N, Jarzab B, Barontini M, Januszewicz A, Shah N, Young W, Opocher G, Eng C, Neumann HPH, Bausch B.

Endocr Relat Cancer. 2018 May 10. pii: ERC-18-0100. doi: 10.1530/ERC-18-0100. [Epub ahead of print]

PMID:
29748190
19.

Characterising the adipose-inflammatory microenvironment in male breast cancer.

Lees T, Cullinane A, Condon A, Shabaan AM, Humphries MP, Speirs V.

Endocr Relat Cancer. 2018 Jul;25(7):773-781. doi: 10.1530/ERC-17-0407. Epub 2018 May 9.

PMID:
29743167
20.

Exploiting insights on the RET receptor for personalized cancer medicine.

Mulligan LM.

Endocr Relat Cancer. 2018 May 9. pii: ERC-18-0141. doi: 10.1530/ERC-18-0141. [Epub ahead of print]

PMID:
29743166

Supplemental Content

Loading ...
Support Center